West on Lung Cancer

• Can Telemedicine Survive? The future of telemedicine remains uncertain. Oncologist Jack West explores how we can give this approach staying power.
  Medscape Oncology, September 15, 2021
• Oncologists Still Failing 'Woefully' at Molecular Testing Oncologist Jack West explores why molecular testing in advanced lung cancer is not happening often enough in the clinic
  Medscape Oncology, September 14, 2021
• Is There a Fix for Willful Medical Ignorance? The widespread rejection of science is now a leading bottleneck in the progress of medicine, argues oncologist Jack West.
  Medscape Oncology, August 23, 2021
• Telemedicine Beyond the Pandemic Telemedicine has long-term potential to close gaps in healthcare -- once we resolve the glitches.
  Medscape Oncology, July 06, 2021
• The Dangers of Incentivizing Mediocrity With 'Me-Too' Drugs Dr Jack West warns us about the very real costs of asking so little of pivotal trials for redundant cancer treatments.
  Medscape Oncology, April 16, 2021
• Sifting Through the Wreckage of 2020: 5 Things Worth Salvaging Treating cancer demands celebrating successes where you can find them. An oncologist looks back at a few of the beneficial adaptations that happened despite an otherwise abysmal year.
  Medscape Oncology, February 08, 2021
• Identity Onco-Politics Is Impairing Our Objectivity We must avoid reflexively toeing a party line when interpreting data, says Dr Jack West.
  Medscape Oncology, February 03, 2021
• Happy Days in Oncology: More Applause, Less Rigor? Dr Jack West worries that in our quest for positive outcomes, we've stopped being thought leaders and become cheerleaders instead.
  Medscape Oncology, December 01, 2020
• Oncology Is Not Immune From Online 'Confirmation Bias' Far too often, online discussions among oncologists cross the line into specious and even dangerous territory.
  Medscape Oncology, October 15, 2020
• 5 Reasons Why Medical Meetings Will Never Be the Same Dr Jack West argues that we shouldn't necessarily rush to return to the previous status quo of live, in-person medical meetings.
  Medscape Oncology, September 09, 2020
• Why Are Oncologists Deviating From Best Evidence in NSCLC? Bringing practices in line with standard of care requires understanding why they're diverging in the first place, says Dr Jack West.
  Medscape Oncology, August 18, 2020
• We Can't Afford to Be 'Cost-Agnostic' With Our Cancer Patients Dr Jack West on how one oncologist's personal experience propelled her to make patients' financial hardships a viable treatment consideration.
  Medscape Oncology, June 11, 2020
• ADAURA Trial: Breaking Through the Hype Drs Jack West and Lecia Sequist discuss the pros and cons of the ADAURA trial, and whether focusing on only disease-free survival is enough for patients with EGFR mutation-positive NSCLC.
  Medscape Oncology, June 05, 2020
• Has 'Patient Centeredness' Gone Too Far? Patient centeredness is not a reason to accede to misguided medical decisions, argues Jack West.
  Medscape Oncology, May 29, 2020
• Why Is the UK so Much Better at Molecular Profiling? Drs Jack West and Sanjay Popat discuss the strengths and limitations of their respective US and UK systems for identifying and treating lung cancer with actionable mutations.
  Medscape Oncology, May 08, 2020
• 5 Key Targeted Therapy Advances for Lung Cancer Drs West and Aggarwal share their thoughts on the past decade's targeted therapy innovations, and how they may keep going well into the 2020s.
  Medscape Oncology, March 26, 2020
• Italian Oncologist's Cautionary Advice on COVID-19 for US Centers Marina Garassino, MD, chief of the Medical Thoracic Oncology Unit at the Istituto Nazionale dei Tumori in Milan, Italy, talks about her experience during Italy's COVID-19 outbreak.
  Medscape Oncology, March 20, 2020
• Top 5 Advances in Lung Cancer Immunotherapy Over the Past Decade Lung cancer experts Jack West and Charu Aggarwal highlight the biggest immunotherapy trials in thoracic oncology from 2010 to 2019.
  Medscape Oncology, January 23, 2020
• Overcoming Territoriality in Palliative Cancer Care Dr Jack West says it is time to embrace a team approach when it comes to initiating discussions about end-of-life care with patients with advanced cancer.
  Medscape Oncology, January 21, 2020
• 'Open Notes': Too Much Transparency With Patients? A new film about a terminal cancer diagnosis, along with his own institution's move to an open notes system, get Dr Jack West to thinking about how we disclose bad news to our patients with cancer.
  Medscape Oncology, November 07, 2019